News from the iDeAC Network

Affiliations

Latest

CODIAK: Harnessing the power of exosomes

Codiak BioSciences is pioneering exosome research and development to create an entirely new class of medicines, exosome therapeutics. There proprietary technology platform for exosome engineering and manufacturing allows precise therapeutic targeting, enabling them to develop therapies that may address a diverse array of diseases that are currently difficult or impossible to treat using existing methodologies.

Funding

Latest

First UK-wide study of brain complications in patients with COVID-19

Researchers from the University of Southampton are amongst a UK team of scientists to conduct the first nationwide surveillance study of the neurological complications of COVID-19. A study of 153 patients treated in UK hospitals during the acute phase of the COVID-19 pandemic describes a range of neurological and psychiatric complications that may be linked to the disease, including stroke and an altered mental state such as brain inflammation, psychosis and dementia-like symptoms.

Meetings

Latest

Research

Latest

First UK-wide study of brain complications in patients with COVID-19

Researchers from the University of Southampton are amongst a UK team of scientists to conduct the first nationwide surveillance study of the neurological complications of COVID-19. A study of 153 patients treated in UK hospitals during the acute phase of the COVID-19 pandemic describes a range of neurological and psychiatric complications that may be linked to the disease, including stroke and an altered mental state such as brain inflammation, psychosis and dementia-like symptoms.